BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
Jessica N. McAlpine(University of British Columbia), C. Blake Gilks(Vancouver General Hospital), Henry Porter(University of British Columbia), Jiarui Ding(Broad Institute), Leah Prentice(University of British Columbia), Brad H. Nelson(University of British Columbia), Katy Milne(University of Victoria), Janine Senz(University of British Columbia), David G. Huntsman(BC Cancer Agency), Steve E. Kalloger(BC Cancer Agency), Martin Köbel(University of Calgary), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center)
Cited by 186
Related Papers
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k